It is remarkable, that the authors focused primarily on distinguishing between carriers and noncarriers of a BRCA1/2 PV (which is essentially equivalent to distinguishing between carriers and noncarriers of a pathogenic alteration in a BC risk gene with high penetrance), but not between BRCA1 and BRCA2 PV carriers per se. This evidence concerns the gene BRCA1 and breast cancer.